The only positive is that the volumes are still relatively low. There are just zero buyers thus the continued falling of the shareprice.
FDA approval will certainly give a confidence boost. Rejection and I'd say its see you later for the short-term shareprice. That's where it stands.
Add to My Watchlist
What is My Watchlist?